Tyme Technologies, Inc. (NASDAQ:TYME)
Industry: Healthcare

Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

Current Quote*
Last: $1.550
Change: -0.030
Book: $10.921
Volume: 377,286

As Of: 04/18 13:27 ET
*Quotes delayed by 20min.

Graphs for TYME


3 Month Graph


6 Month Graph


1 Year Graph